# A Pilot Study of Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging

> **NCT02633241** · PHASE4 · COMPLETED · sponsor: **Joseph Cravero** · enrollment: 71 (actual)

## Conditions studied

- Epilepsy
- Cerebral Palsy
- Developmental Delay

## Interventions

- **DRUG:** Dexmedetomidine bolus and high infusion-Propofol
- **DRUG:** Dexmedetomidine bolus and low infusion-Propofol
- **DRUG:** Dexmedetomidine bolus only - Propofol

## Key facts

- **NCT ID:** NCT02633241
- **Lead sponsor:** Joseph Cravero
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-02
- **Primary completion:** 2022-09-06
- **Final completion:** 2022-09-06
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2023-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02633241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02633241, "A Pilot Study of Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02633241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*